Home › Astrocytoma › Massachusetts › Boston

Pag-aaral pangklinika para sa Astrocytoma sa Boston, MA

Isang pag-aaral para sa Astrocytoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Boston. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

Nagre-recruitPhase 1/2

Research Site, Boston

Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05417594

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

Nagre-recruitPhase 3

Tufts Medical Center, Boston
Massachusetts General Hospital Cancer Center, Boston
Dana-Farber Cancer Institute, Boston

Edad 12 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07215910

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Nagre-recruitPhase 1/2

Tufts Medical Center, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06047379

Targeted Pediatric High-Grade Glioma Therapy

Nagre-recruitObservasyonal na pag-aaral

Dana-Farber Cancer Institute, Boston

12 Months – 39 Years · Lahat ng kasarian · Na-update Set 8, 2026 · NCT05839379

Serial MRI Scans During Radiation Therapy

Nagre-recruit

Brigham and Women Hospital, Boston
Dana Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT04188535

Study of Olutasidenib and Temozolomide in HGG

Nagre-recruitPhase 2

Susan Chi, Boston

Edad 12 hanggang 39 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06161974

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Nagre-recruitPhase 3

Massachusetts General Hospital, Boston
Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT05303519

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

Nagre-recruitMaagang Phase 1Malugod na tinatanggap ang malusog na boluntaryo

Dana-Farber Cancer Institute, Boston

Edad 1 hanggang 21 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT06333899

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Nagre-recruitPhase 2

Dana-Farber Cancer Institute, Boston

12 Months – 39 Years · Lahat ng kasarian · Na-update May 29, 2026 · NCT05843253

Implantable Microdevice In Primary Brain Tumors

Nagre-recruitMaagang Phase 1

Brigham and Women's Hospital, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 23, 2025 · NCT04135807

The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)

Nagre-recruitObservasyonal na pag-aaral

Massachusetts General Hospital, Boston

Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Peb 28, 2024 · NCT06283927

The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)

Nagre-recruitObservasyonal na pag-aaral

Massachusetts General Hospital, Boston

Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Peb 22, 2024 · NCT06118723

The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma

Nagre-recruitObservasyonal na pag-aaral

Massachusetts General Hospital, Boston

Hanggang edad 90 · Lahat ng kasarian · Na-update Peb 22, 2024 · NCT06273176

Pag-aaral para sa Astrocytoma sa ibang lungsod

Iba pang pag-aaral sa Boston

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.